We are live on ! Find out more
AZUL

Azul

Delisted

AZUL was delisted on the 27th of May, 2025.

81 hedge funds and large institutions have $275M invested in Azul in 2022 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 25 increasing their positions, 24 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

182% more call options, than puts

Call options by funds: $18.2M | Put options by funds: $6.47M

15% more capital invested

Capital invested by funds: $240M → $275M (+$35.3M)

4% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 24

0.01% more ownership

Funds ownership: 10.07%10.07% (+0.01%)

0% more funds holding

Funds holding: 8181 (0)

0% more first-time investments, than exits

New positions opened: 17 | Existing positions closed: 17

Holders
81
Holders Change
Holders Change %
0%
% of All Funds
1.39%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
17
Increased
25
Reduced
24
Closed
17
Calls
$18.2M
Puts
$6.47M
Net Calls
+$11.8M
Net Calls Change
+$9.48M

AZUL Hedge Fund Activity: Q3 2022 in Review

81 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Azul (AZUL) for Q3 2022, worth a combined $275M — up 15% from $240M a quarter earlier.

Fund positioning in AZUL was balanced in Q3 2022: 17 funds opened new positions, 17 closed out, 25 added to existing stakes and 24 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $9.72M. The largest seller was Morgan Stanley, cutting an estimated $6.98M.

  • 81 institutional investors held Azul (AZUL) as of Q3 2022, unchanged from Q2 2022.
  • Funds reported $275M of Azul stock for Q3 2022, up 15% quarter-over-quarter.
  • 17 funds opened new Azul positions in Q3 2022 and 17 closed out, a net change of 0 holders.
  • The largest Azul buyer in Q3 2022 was Citadel Advisors, an estimated $9.72M added.
  • The largest Azul seller in Q3 2022 was Morgan Stanley, an estimated $6.98M sold.

Based on aggregated 13F filings for Q3 2022.